Knowledge Exchange by ISID

About this activity
Learning Objectives
Discussion Forum (0)
Rate & Comment (0)
This webinar is Open-Access (no login required) and was hosted on April 27, 2020 9:00 am - 10:00 am EDT (BST: 2pm - 3pm / GMT: 1pm - 2pm).
A post-produced on-demand version (with slide navigation) is available.

Seasonal Influenza: Global Burden, Prevention and the impact of COVID-19 on Surveillance and Transmission
Chair and Discussion Moderator: Patricio Acosta(Argentina)
Co-Chair: Therese Umuhoza(Rwanda)
The Global Burden of Influenza on Morbidity and Mortality By Ann Falsey(US)
The Impact of Influenza Vaccines on Public Health By Zamberi Sekawi(Malaysia)
The Impact of COVID-19 on Influenza on Surveillance and Transmission By Bruno Lina(France)

This webinar is supported by an unrestricted educational grant from Sanofi Pasteur.

Survey
Your opinion matters to us! Please take 2 minutes after the session to answer a quick survey: 
https://isid.typeform.com/to/SJZspiiC

Technical Settings
This Live Session is available on all latest browsers. For the best viewing experience, a high-speed internet connection is required
If you have a problem getting access to the live webinar, please contact the technical crew at support@multilearning.com.

WHO estimates that seasonal influenza may result in 290,000 – 650,000 deaths each year due to respiratory diseases alone. This estimate does not take into account deaths from other diseases such as cardiovascular disease, which can be influenza-related. Surveillance and laboratory studies of all influenza-related diseases are ongoing and are expected to reveal substantially higher estimates of disease burden. Webinar attendees will engage with experts who will provide updates on global influenza surveillance efforts and estimated burden of disease. They will discuss the importance of country-level influenza estimates to inform national and global preparedness, prevention and control efforts and will highlight remaining gaps. The clinical, social, and economic advances gained from expanded access and uptake of influenza vaccines will be addressed and the lack of reliable data on the possible impact of vaccination among specific high-risk groups will be highlighted.  
 
The full impact of COVID-19 and nonpharmaceutical interventions on seasonal influenza remains to be determined. Experts will discuss questions around the impact of COVID-19 on influenza surveillance, the role of genomic sequencing for influenza surveillance as a way to better understand disease spread and improve prevention efforts and what to expect during the next influenza season. 

Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies